Central action of prosaptide TX14(A) against gp120-induced allodynia in rats

European Journal of Pain

Volumn 12, Issue 1, 2008, Pages 76-81

  Jolivalt, Corinne G ^a   daCunha, Joice M ^a   Esch, Fred S ^b   Calcutt, Nigel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Myelos Neurosciences   (United States)

Author keywords

Allodynia; gp120; HIV; Neuropathic pain; Prosaposin

Indexed keywords

GLYCOPROTEIN GP 120; PROSAPOSIN; TUMOR NECROSIS FACTOR ALPHA; TX14(A); UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL NERVE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOT; HIV ENVELOPE PROTEIN GP120; HYPERALGESIA; INJECTIONS; INJECTIONS, SPINAL; NERVE GROWTH FACTORS; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; TOUCH;

EID: 35748956846     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2007.03.008     Document Type: Article

References (26)

1. Bagetta G., Corasaniti M.T., Malorni W., Rainaldi G., Berliocchi L., Finazzi-Agro A., et al. The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport 7 (1996) 1722-1724
2. Bodner A., Toth P.T., and Miller R.J. Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity. Exp Neurol 188 (2004) 246-253
3. Brinley Jr. F.J., Pardo C.A., and Verma A. Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 58 (2001) 1561-1566
4. Buriani A., Petrelli L., Facci L., Romano P.G., Dal Tosso R., Leon A., et al. Human immunodeficiency virus type 1 envelope glycoprotein gp120 induces tumor necrosis factor-alpha in astrocytes. J NeuroAIDS 2 (1999) 1-13
5. Calcutt N.A., Campana W.M., Eskeland N.L., Mohiuddin L., Dines K.C., Mizisin A.P., et al. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J Neuropathol Exp Neurol 58 (1999) 628-636
6. Calcutt N.A., Freshwater J.D., and O'Brien J.S. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology 93 (2000) 1271-1278
7. Campana W.M., Eskeland N., Calcutt N.A., Misasi R., Myers R.R., and O'Brien J.S. Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology 9 (1998) 237-244
8. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 53 (1994) 55-63
9. Courteix C., Bourget P., Caussade F., Bardin M., Coudore F., Fialip J., et al. Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?. J Pharmacol Exp Ther 285 (1998) 63-70
10. Eron Jr. J.J., Ashby M.A., Giordano M.F., Chernow M., Reiter W.M., Deeks S.G., et al. Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection. Lancet 348 (1996) 1547-1551
11. Everall I.P., Bell C., Mallory M., Langford D., Adame A., Rockestein E., et al. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci 21 (2002) 493-501
12. George A., Schmidt C., Weishaupt A., Toyka K.V., and Sommer C. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 160 (1999) 124-132
13. Herzberg U., and Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 116 (2001) 29-39
14. Holguin A., O'Connor K.A., Biedenkapp J., Campisi J., Wieseler-Frank J., Milligan E.D., et al. HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 110 (2004) 517-530
15. Jolivalt C.G., Ramos K.M., Herbetsson K., Esch F.S., and Calcutt N.A. Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Pain 121 (2006) 14-21
16. Keswani S.C., Polley M., Pardo C.A., Griffin J.W., McArthur J.C., and Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 54 (2003) 287-296
17. Koka P., He K., Zack J.A., Kitchen S., Peacock W., Fried I., et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 182 (1995) 941-951
18. Ledeboer A., Gamanos M., Lai W., Martin D., Maier S.F., Watkins L.R., et al. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 22 (2005) 1977-1986
19. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 861 (2000) 105-116
20. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21 (2001) 2808-2819
21. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., and Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21 (2001) 5027-5035
22. Taylor E.M., Otero D.A., Banks W.A., and O'Brien J.S. Retro-inverso prosaptide peptides retain bioactivity, are stable in vivo, and are blood-brain barrier permeable. J Pharmacol Exp Ther 295 (2000) 190-194
23. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 6 (2001) 8-13
24. Wagner R., Myers R.R., and O'Brien J.S. Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. Neuroreport 9 (1998) 2827-2831
25. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
26. Yaksh T.L., and Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science 192 (1976) 1357-1358